Aligos Therapeutics (ALGS) Return on Equity [ROE] (2020 - 2026)
Aligos Therapeutics (ALGS) posted Return on Equity [ROE] of -307.03% for Q3 2026, down 207.34 percentage points from -99.69% a year earlier and down 68.48 percentage points from the prior quarter.
Aligos Therapeutics (ALGS) Return on Equity [ROE] (2020 - 2026) Analysis & Trends
For FY2025, Aligos Therapeutics' Return on Equity [ROE] came in at -196.78%, up 219.36 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a five-year change of -56.76 percentage points (FY2020 to FY2025).
- In prior years, Aligos Therapeutics' Return on Equity [ROE] was -416.13% in FY2024 (-326.80 pp), -89.33% in FY2023 (-22.74 pp), -66.59% in FY2022 (-3.49 pp) and -63.09% in FY2021 (+76.92 pp).
- The Q3 2026 figure stands as the lowest quarterly Return on Equity [ROE] since Q4 2024.
- On a year-over-year basis, Return on Equity [ROE] has declined in each of the last three quarters, with an average year-over-year change of -36.90 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q4 2025, with a gain of 1204.68 percentage points; the weakest was Q4 2024, with a drop of 1124.07 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -238.55% (Q2 2026), -211.71% (Q1 2026) and -38.56% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | - |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 4.66% |
| 10 | Aligos Therapeutics | 21.97 Mn | -314.86 Mn | - | -307.03% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -307.03% |
| Jun 30, 2026 | -238.55% |
| Mar 31, 2026 | -211.71% |
| Dec 31, 2025 | -38.56% |
| Sep 30, 2025 | -99.69% |
| Jun 30, 2025 | -68.03% |
| Mar 31, 2025 | -121.84% |
| Dec 31, 2024 | -1,243.24% |
| Sep 30, 2024 | -131.04% |
| Jun 30, 2024 | -119.25% |
| Mar 31, 2024 | -131.17% |
| Dec 31, 2023 | -119.18% |
| Sep 30, 2023 | -130.70% |
| Jun 30, 2023 | -105.98% |
| Mar 31, 2023 | -88.09% |
| Dec 31, 2022 | -85.07% |
| Sep 30, 2022 | -86.08% |
| Jun 30, 2022 | -86.99% |
| Mar 31, 2022 | -80.47% |
| Dec 31, 2021 | -63.57% |
Aligos Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ALGS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();